Company: GRCE
Filing Date: 2025-11-17
Form Type: 10-Q/A
Source: 0001140361-25-042491
Chunk: 2

Company: Grace Therapeutics, Inc.
Filing Date: 2025-11-17
Form: 10-Q/A
Chunk 2
---
 Report on Form 8-K filed with the Commission on October 28, 2024)                                                                       |
|:-----------|:----|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.3        |     | Bylaws of Grace Therapeutics, Inc. (incorporated by reference to Exhibit 3.2 on the Current Report on Form 8-K filed with the Commission on October 28, 2024)                                                                                                                             |
| 10.1†

#     |     | Amendment No. 1 to Letter Agreement by and between Prashant Kohli and the Company, dated November 12, 2025 (incorporated by reference to Exhibit 10.1 on the Quarterly Report on Form 10-Q filed with the Commission on November 13, 2025)                                                |
| 10.2†

#     |     | Letter Agreement by and between Robert J. DelAversano and the Company, dated November 12, 2025 (incorporated by reference to Exhibit 10.2 on the Quarterly Report on Form 10-Q filed with the Commission on November 13, 2025)                                                            |
| 10.3†

#     |     | Letter Agreement by and between Amresh Kumar and the Company, dated November 12, 2025 (incorporated by reference to Exhibit 10.3 on the Quarterly Report on Form 10-Q filed with the Commission on November 13, 2025)                                                                     |
| 10.4†

#     |     | Letter Agreement by and between Carrie D’Andrea and the Company, dated November 12, 2025 (incorporated by reference to Exhibit 10.4 to the Quarterly Report on Form 10-Q filed with the Commission on November 13, 2025)                                                                  |
| 10.5†

#     |     | Letter Agreement by and between R. Loch Macdonald and the Company, dated November 12, 2025 (incorporated by reference to Exhibit 10.5 to the Quarterly Report on Form 10-Q filed with the Commission on November 13, 2025)                                                                |
| 31.1*      |     | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934                                                                                                                                                                   |
| 31.2*      |     | Certification of Principal Financial Officer pursuant to Rule 13